发明名称 HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS
摘要 Compounds of formula (I), are useful for inhibiting matrix metalloproteinase enzymes in animals, and as such, prevent and treat diseases resulting from the breakdown of connective tissues. Also disclosed are methods for the preparation of such compounds, pharmaceutical compositions including the same, and methods of treating diseases in which matrix metalloproteinases are involved including multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurysm, heart failure, periodontal disease, corneal ulceration, burns, decubital ulcers, chronic ulcers or wounds, cancer metastasis, tumor angiogenesis, osteoporosis, rheumatoid or osteoarthritis, renal disease, left ventricular dilation, or other autoimmune or inflammatory diseases dependent upon tissue invasion by leukocytes.
申请公布号 WO0112592(A3) 申请公布日期 2001.07.05
申请号 WO2000US21884 申请日期 2000.08.10
申请人 WARNER-LAMBERT COMPANY;CONRAD, CHRISTOPHER, ALAN;O'BRIEN, PATRICK, MICHAEL;ORTWINE, DANIEL, FRED;PICARD, JOSEPH, ARMAND;SLISKOVIC, DRAGO, ROBERT 发明人 CONRAD, CHRISTOPHER, ALAN;O'BRIEN, PATRICK, MICHAEL;ORTWINE, DANIEL, FRED;PICARD, JOSEPH, ARMAND;SLISKOVIC, DRAGO, ROBERT
分类号 A61K31/18;A61K31/196;A61K31/198;A61K31/343;A61K31/351;A61P1/02;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/14;A61P13/12;A61P17/02;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P29/00;A61P31/18;A61P35/00;A61P37/02;A61P43/00;C07C311/19;C07C311/20;C07D307/91;C07D307/93;C07D407/12;(IPC1-7):C07C311/20 主分类号 A61K31/18
代理机构 代理人
主权项
地址